Skip to main content

Find Clinical Trials

Home
Conditions
Ovarian Carcinoma

Clinical trial condition

Ovarian Carcinoma

Explore clinical trials studying Ovarian Carcinoma. Study availability and eligibility vary by location and protocol.

110 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Ovarian Carcinoma trial results

Not Yet Recruiting

International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis

NCT06393543

Conditions: Adnexal Diseases, BRCA Mutation, Endocrine Gland Neoplasms, +16 more
Locations: Not specified

View Trial Details

Completed

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

NCT03180294

Conditions: Adnexal Diseases, Breast Carcinoma, Breast Diseases, +31 more
Locations: Kaiser Permanente-Anaheim Anaheim, California, United States

Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States

Kaiser Permanente-Baldwin Park Baldwin Park, California, United States

Kaiser Permanente-Bellflower Bellflower, California, United States

View all 362 locations

View Trial Details

Completed

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

NCT05494580

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Sun Yat-sen University Cancer Cetntre Guangzhou, China

View Trial Details

Completed

Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss

NCT03027479

Conditions: Adnexal Diseases, Body Weight, Body Weight Changes, +27 more
Locations: Gynecology Department, University Teaching Hospital, Tours Tours, France

View Trial Details

Completed

A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

NCT05001347

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +36 more
Locations: Arizona Oncology Associates Tucson, Arizona, United States

Innovative Clinical Research Institute Whittier, California, United States

Medical Oncology Hematology Consultants, PA Newark, Delaware, United States

Illinois Cancer Specialists Arlington Heights, Illinois, United States

View all 15 locations

View Trial Details

Completed

Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

NCT06870539

Conditions: Adnexal Diseases, Cancer-related Cognitive Dysfunction, Cytomegaloviral Infection, +24 more
Locations: University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

A Trial Evaluating TG4050 in Ovarian Carcinoma.

NCT03839524

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Mayo Clinic Phoenix Phoenix, Arizona, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Mayo Clinic Rochester Rochester, Minnesota, United States

Institut Curie Paris, France

View Trial Details

Completed

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02159989

Conditions: Adenoma, Adenoma, Islet Cell, Adnexal Diseases, +33 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)

NCT05446870

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: University of Colorado Anschutz Medical Campus-Cancer Clinical Trials Office ( Site 0108) Aurora, Colorado, United States

Mayo Clinic in Florida ( Site 0101) Jacksonville, Florida, United States

Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) Miami, Florida, United States

Northwestern Memorial Hospital ( Site 0104) Chicago, Illinois, United States

View all 45 locations

View Trial Details

Completed

Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.

NCT03085225

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Institut Bergonié Bordeaux, France

Centre Léon Bérard Lyon, France

View Trial Details